Literature DB >> 25561726

Glycogen synthase kinase-3 (GSK3) inhibition induces prosurvival autophagic signals in human pancreatic cancer cells.

Benoît Marchand1, Dominique Arsenault1, Alexandre Raymond-Fleury1, François-Michel Boisvert2, Marie-Josée Boucher3.   

Abstract

Glycogen synthase kinase-3 (GSK3) are ubiquitously expressed serine-threonine kinases involved in a plethora of functions ranging from the control of glycogen metabolism to transcriptional regulation. We recently demonstrated that GSK3 inhibition triggers JNK-cJUN-dependent apoptosis in human pancreatic cancer cells. However, the comprehensive picture of downstream GSK3-regulated pathways/functions remains elusive. Herein, counterbalancing the death signals, we show that GSK3 inhibition induces prosurvival signals through increased activity of the autophagy/lysosomal network. Our data also reveal a contribution of GSK3 in the regulation of the master transcriptional regulator of autophagy and lysosomal biogenesis, transcription factor EB (TFEB) in pancreatic cancer cells. Similarly to mammalian target of rapamycin (mTOR) inhibition, GSK3 inhibitors promote TFEB nuclear localization and leads to TFEB dephosphorylation through endogenous serine/threonine phosphatase action. However, GSK3 and mTOR inhibition impinge differently and independently on TFEB phosphorylation suggesting that TFEB is regulated by a panel of kinases and/or phosphatases. Despite their differential impact on TFEB phosphorylation, both GSK3 and mTOR inhibitors promote 14-3-3 dissociation and TFEB nuclear localization. Quantitative mass spectrometry analyses further reveal an increased association of TFEB with nuclear proteins upon GSK3 and mTOR inhibition suggesting a positive impact on TFEB transcriptional function. Finally, a predominant nuclear localization of TFEB is unveiled in fully fed pancreatic cancer cells, whereas a reduction in TFEB expression significantly impairs their capacity for growth in an anchorage-independent manner. In addition, TFEB-restricted cells are more sensitive to apoptosis upon GSK3 inhibition. Altogether, our data uncover new functions under the control of GSK3 in pancreatic cancer cells in addition to providing key insight into TFEB regulation.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  14-3-3 Protein; Apoptosis; Autophagy; Glycogen Synthase Kinase 3 (GSK-3); Pancreatic Cancer; Transcription Factor

Mesh:

Substances:

Year:  2015        PMID: 25561726      PMCID: PMC4342473          DOI: 10.1074/jbc.M114.616714

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

Review 1.  GSK3 inhibitors: development and therapeutic potential.

Authors:  Philip Cohen; Michel Goedert
Journal:  Nat Rev Drug Discov       Date:  2004-06       Impact factor: 84.694

Review 2.  Autophagy and metabolism.

Authors:  Joshua D Rabinowitz; Eileen White
Journal:  Science       Date:  2010-12-03       Impact factor: 47.728

3.  Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation.

Authors:  K P Hoeflich; J Luo; E A Rubie; M S Tsao; O Jin; J R Woodgett
Journal:  Nature       Date:  2000-07-06       Impact factor: 49.962

4.  The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis.

Authors:  Agnes Roczniak-Ferguson; Constance S Petit; Florian Froehlich; Sharon Qian; Jennifer Ky; Brittany Angarola; Tobias C Walther; Shawn M Ferguson
Journal:  Sci Signal       Date:  2012-06-12       Impact factor: 8.192

5.  Maintenance of constitutive IkappaB kinase activity by glycogen synthase kinase-3alpha/beta in pancreatic cancer.

Authors:  Willie Wilson; Albert S Baldwin
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

Review 6.  Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases.

Authors:  D M Owens; S M Keyse
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

7.  Autophagy promotes BrafV600E-driven lung tumorigenesis by preserving mitochondrial metabolism.

Authors:  Anne M Strohecker; Eileen White
Journal:  Autophagy       Date:  2013-12-17       Impact factor: 16.016

8.  Glycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-β precursor protein.

Authors:  Callum Parr; Raffaela Carzaniga; Steve M Gentleman; Fred Van Leuven; Jochen Walter; Magdalena Sastre
Journal:  Mol Cell Biol       Date:  2012-08-27       Impact factor: 4.272

9.  A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB.

Authors:  Carmine Settembre; Roberto Zoncu; Diego L Medina; Francesco Vetrini; Serkan Erdin; SerpilUckac Erdin; Tuong Huynh; Mathieu Ferron; Gerard Karsenty; Michel C Vellard; Valeria Facchinetti; David M Sabatini; Andrea Ballabio
Journal:  EMBO J       Date:  2012-02-17       Impact factor: 11.598

Review 10.  Glycogen synthase kinase-3 beta; a new target in pancreatic cancer?

Authors:  G Garcea; M M Manson; C P Neal; C J Pattenden; C D Sutton; A R Dennison; D P Berry
Journal:  Curr Cancer Drug Targets       Date:  2007-05       Impact factor: 3.428

View more
  71 in total

1.  Ataxia telangiectasia mutated kinase deficiency impairs the autophagic response early during myocardial infarction.

Authors:  Patsy R Thrasher; Stephanie L C Scofield; Suman Dalal; Claire C Crawford; Mahipal Singh; Krishna Singh
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-04-13       Impact factor: 4.733

2.  Intracellular calcium signaling regulates autophagy via calcineurin-mediated TFEB dephosphorylation.

Authors:  Yanju Tong; Fuyong Song
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

Review 3.  Molecular Mechanisms of Lysosome and Nucleus Communication.

Authors:  Qian Zhao; Shihong Max Gao; Meng C Wang
Journal:  Trends Biochem Sci       Date:  2020-07-02       Impact factor: 13.807

Review 4.  At a glance: A history of autophagy and cancer.

Authors:  Xin Wen; Daniel J Klionsky
Journal:  Semin Cancer Biol       Date:  2019-11-07       Impact factor: 15.707

5.  Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses.

Authors:  Ilyas Sahin; Aditya Eturi; Andre De Souza; Sahithi Pamarthy; Fabio Tavora; Francis J Giles; Benedito A Carneiro
Journal:  Cancer Biol Ther       Date:  2019-04-12       Impact factor: 4.742

6.  Protein kinase C controls lysosome biogenesis independently of mTORC1.

Authors:  Yang Li; Meng Xu; Xiao Ding; Chen Yan; Zhiqin Song; Lianwan Chen; Xiahe Huang; Xin Wang; Youli Jian; Guihua Tang; Changyong Tang; Yingtong Di; Shuzhen Mu; Xuezhao Liu; Kai Liu; Ting Li; Yingchun Wang; Long Miao; Weixiang Guo; Xiaojiang Hao; Chonglin Yang
Journal:  Nat Cell Biol       Date:  2016-09-12       Impact factor: 28.824

Review 7.  Myocardial autophagic energy stress responses--macroautophagy, mitophagy, and glycophagy.

Authors:  Lea M D Delbridge; Kimberley M Mellor; David J R Taylor; Roberta A Gottlieb
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-03-06       Impact factor: 4.733

Review 8.  14-3-3 proteins: an important regulator of autophagy in diseases.

Authors:  Haoyuan Jia; Zhaofeng Liang; Xu Zhang; Juanjuan Wang; Wenrong Xu; Hui Qian
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

9.  Lysosome enlargement during inhibition of the lipid kinase PIKfyve proceeds through lysosome coalescence.

Authors:  Christopher H Choy; Golam Saffi; Matthew A Gray; Callen Wallace; Roya M Dayam; Zhen-Yi A Ou; Guy Lenk; Rosa Puertollano; Simon C Watkins; Roberto J Botelho
Journal:  J Cell Sci       Date:  2018-05-21       Impact factor: 5.285

10.  Controlling Directed Protein Interaction Networks in Cancer.

Authors:  Krishna Kanhaiya; Eugen Czeizler; Cristian Gratie; Ion Petre
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.